Lattice Semiconductor Corporation (NASDAQ:LSCC) recorded a trading volume of 1.45 million shares, above its 90-day volume average of 1.11 million shares. The stock kicked off the session at $6.26 and later approached $6.02 with a change of -4.44%.Lattice Semiconductor Corporation (LSCC) Analyst Opinion
Lattice Semiconductor Corporation has a consensus outperform rating from 3 Wall Street analysts, and the number of shares currently sold short amount to at least 2.6% of shares outstanding. The stock spiked 0.67% last month and is up 4.15 this year. Wall Street is only getting more bullish on the stock, with 1 of analysts who cover LSCC having a buy-equivalent rating. Analysts have placed a $6.25 price target on Lattice Semiconductor Corporation, suggesting a 3.82% gain from recent close. It’s currently trading about -20.26% below its 52-week high.
Lattice Semiconductor Corporation (LSCC) surprised the stock market in its last reported earnings when it earned $0.04 a piece versus the consensus-estimated $0.01. Its revenue totaled $92.05 million down -2.22% from the previous quarter.Lattice Semiconductor Corporation (NASDAQ:LSCC) Intraday View
This stock (LSCC) is ahead of its 52-week low with 19.21%. Its last month’s stock price volatility remained 3.28% which for the week stands at 3.24%. The share price has moved backward from its 20 days moving average, trading at a distance of -4.95% and stays -0.85% away from its 50 days moving average. Over the last five days, shares have faced -9.75% losses and now is down -3.4% since hitting its 200-day moving average of $5.97. Lattice Semiconductor Corporation (LSCC) has made its way to a 12-month decline of -18.1%.
Turning to Axovant Sciences Ltd. (NASDAQ:AXON), its shares were trading at $1.98 a gain of $0.06, on the trading floor. The stock, after opening at $1.9, touched a high of $2.11 before paring much of its gains. So far, analysts are sticking with their neutral recommendations with the consensus call at 2.7. Axovant Sciences Ltd. has 0 buy ratings, 6 holds and 0 sells even after the stock tumbled -92.92% from its high of $27.98 to a $225.54 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2.67 to 2.67 during a month. Analysts set a 12-month price target of $11.22 a share. The target implies a 466.67% spike from where the shares are currently trading. Also, the current price highlights a discount of 1162.63% to analysts’ high consensus price target.Axovant Sciences Ltd. (NASDAQ:AXON) Intraday Trading
The counter witnessed a trading volume of 2.28 million shares versus an average volume of 1.54 million shares during last trading session. Its last month’s stock price volatility remained 6.71% which for the week approaches 7.5%. The lowest price the stock reached in the last trading day was $1.89 and compares with the $1.88 52-week low. The stock recovered 5.32% since its low point and has performed -62.43% year-to-date.